Andreas Puschnik

Title: Innovations of Andreas Puschnik

Introduction

Andreas Puschnik is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of biotechnology, particularly in the modulation of adeno-associated virus (AAV) infection. His work has implications for gene therapy and other medical applications.

Latest Patents

Andreas Puschnik holds a patent titled "Methods and compositions for modulating AAV infection." This patent includes compositions and methods designed to enhance or reduce the permissiveness of target cells to AAV infection. For instance, the methods involve increasing levels of AAVR (KIAA0319L) in the cell to enhance infection or reducing AAVR levels to decrease infection. Additionally, the patent covers nucleic acid delivery methods that utilize AAV particles containing nucleic acids of interest. The patent is a valuable asset in the ongoing research and development of gene therapy techniques.

Career Highlights

Throughout his career, Puschnik has worked with prestigious institutions such as Leland Stanford Junior University and Oregon Health & Science University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Andreas Puschnik has collaborated with notable colleagues, including Sirika Pillay and Jan E Carette. These partnerships have furthered his research and expanded the impact of his innovations in biotechnology.

Conclusion

Andreas Puschnik's work in modulating AAV infection represents a significant advancement in the field of gene therapy. His patent and collaborations highlight his commitment to innovation and the potential for future breakthroughs in medical science.